NASDAQ:VYGR | Free Cash Flow | Voyager Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$33.42M$14,000.00-$33.43M
2025-12-31-$30.26M$626,000.00-$30.89M
2025-03-31-$37.9M$658,000.00-$38.55M
2024-12-31-$14.53M$155,000.00-$14.68M
2024-03-31$58.77M$2.14M$56.63M
2023-12-31-$23.76M$755,000.00-$24.52M-43.47%
2023-03-31$123.57M$509,000.00$123.06M99.20%
2022-12-31-$12.24M$933,000.00-$13.18M
2022-03-31$34.43M$38,000.00$34.39M
2021-12-31$11.2M$347,000.00$10.85M190.02%
2021-03-31-$21.29M$375,000.00-$21.67M
2020-12-31-$21.98M$3.56M-$25.53M
2020-03-31-$28.8M$1.51M-$30.31M
2019-12-31-$23.36M$3.38M-$26.74M
2019-03-31$125.16M$1.1M$124.06M
2018-12-31-$24.35M$523,000.00-$24.87M
2018-03-31$48.61M$1.61M$47M
2017-12-31-$14.83M$161,000.00-$15M
2017-03-31-$14.29M$2.95M-$17.24M
2016-12-31-$13.09M$3.87M-$16.96M
2016-03-31-$9.49M$460,000.00-$9.95M
2015-12-31-$9.56M$121,000.00-$9.68M
2015-03-31$64.59M$150,000.00$64.44M
2014-12-31-$4.79M$1.01M-$5.8M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$132.47M$2.6M-$135.06M
2024-12-31-$15.31M$3.52M-$18.83M
2023-12-31$77.92M$3.26M$74.66M56.42%
2022-12-31-$12.51M$2.49M-$15M
2021-12-31-$53.53M$1.61M-$55.13M
2020-12-31-$96.72M$12.1M-$108.81M-296.16%
2019-12-31$48.67M$7.72M$40.95M
2018-12-31-$15.89M$4.31M-$20.19M
2017-12-31-$61.35M$3.99M-$65.34M
2016-12-31-$42.48M$5.03M-$47.51M
2015-12-31$41.3M$1.03M$40.27M
2014-12-31-$11.92M$2.99M-$14.91M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.